Hello, not smart enough to know if this implies good or bad news?? but Dr. Otto Yang, at the 53ish minute mark in the video (i saw it posted here weeks ago) states unenthusiastically that Leronlimab patients are responsive in “half to two-thirds of cases” ....
My take is 1) these are EIND cases - very ill population - as we know from reading the paper. and 2) in the other portions of video he sounds cautiously optimistic (24:00, 32:25)..